» Articles » PMID: 22201290

Small-molecule-modified Surfaces Engage Cells Through the αvβ3 Integrin

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2011 Dec 29
PMID 22201290
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Integrins play myriad and vital roles in development and disease. They connect a cell with its surroundings and transmit chemical and mechanical signals across the plasma membrane to the cell's interior. Dissecting their roles in cell behavior is complicated by their overlapping ligand specificity and shared downstream signaling components. In principle, immobilized synthetic peptides can mimic extracellular matrix proteins by supporting integrin-mediated adhesion, but most short peptide sequences lack selectivity for one integrin over others. In contrast, synthetic integrin antagonists can be highly selective. We hypothesized that this selectivity could be exploited if antagonists, when immobilized, could support cellular adhesion and activate signaling by engaging specific cell-surface integrins. To investigate this possibility, we designed a bifunctional (RGD)-based peptidomimetic for surface presentation. Our conjugate combines a high affinity integrin ligand with a biotin moiety; the former engages the α(v)β(3) integrin, and the latter allows for presentation on streptavidin-coated surfaces. Surfaces decorated with this ligand promote both cellular adhesion and integrin activation. Moreover, the selectivity of these surfaces for the α(v)β(3) integrin can be exploited to capture a subset of cells from a mixed population. We anticipate that surfaces displaying highly selective small molecule ligands can reveal the contributions of specific integrin heterodimers to cell adhesion and signaling.

Citing Articles

Synthesis and Evaluation of a Non-Peptide Small-Molecule Drug Conjugate Targeting Integrin αβ.

Paulus J, Sewald N Front Chem. 2022; 10:869639.

PMID: 35480387 PMC: 9035832. DOI: 10.3389/fchem.2022.869639.


Combining Biologically Active β-Lactams Integrin Agonists with Poly(l-lactic acid) Nanofibers: Enhancement of Human Mesenchymal Stem Cell Adhesion.

Martelli G, Bloise N, Merlettini A, Bruni G, Visai L, Focarete M Biomacromolecules. 2020; 21(3):1157-1170.

PMID: 32011862 PMC: 7997109. DOI: 10.1021/acs.biomac.9b01550.


Long-Term Maintenance of Human Pluripotent Stem Cells on cRGDfK-Presenting Synthetic Surfaces.

Lambshead J, Meagher L, Goodwin J, Labonne T, Ng E, Elefanty A Sci Rep. 2018; 8(1):701.

PMID: 29335618 PMC: 5768753. DOI: 10.1038/s41598-018-19209-0.


Signals from the surface modulate differentiation of human pluripotent stem cells through glycosaminoglycans and integrins.

Wrighton P, Klim J, Hernandez B, Koonce C, Kamp T, Kiessling L Proc Natl Acad Sci U S A. 2014; 111(51):18126-31.

PMID: 25422477 PMC: 4280649. DOI: 10.1073/pnas.1409525111.


Defining synthetic surfaces for human pluripotent stem cell culture.

Lambshead J, Meagher L, OBrien C, Laslett A Cell Regen. 2014; 2(1):7.

PMID: 25408879 PMC: 4230363. DOI: 10.1186/2045-9769-2-7.


References
1.
Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kessler H . Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem. 1994; 269(32):20233-8. View

2.
CRAM D . The design of molecular hosts, guests, and their complexes. Science. 1988; 240(4853):760-7. View

3.
Carlson C, Mowery P, Owen R, Dykhuizen E, Kiessling L . Selective tumor cell targeting using low-affinity, multivalent interactions. ACS Chem Biol. 2007; 2(2):119-27. DOI: 10.1021/cb6003788. View

4.
Kramer R, Karpen J . Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature. 1998; 395(6703):710-3. DOI: 10.1038/27227. View

5.
Carman C, Springer T . Integrin avidity regulation: are changes in affinity and conformation underemphasized?. Curr Opin Cell Biol. 2003; 15(5):547-56. DOI: 10.1016/j.ceb.2003.08.003. View